OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56‐Week PREEMPT Clinical Program

2011296 citationsJournal Article

Authors

Repeated treatment with ≤ 5 cycles of onabotulinumtoxinA was effective, safe, and well tolerated in adults with chronic migraine.

Good health and well-being

Published in: Headache The Journal of Head and Face Pain

Volume 51, Issue 9, pp. 1358-1373

Field-Weighted Citation Impact: 8.89